Similar to our study, previous risk models [16, 26–28] have attempted to employ pre-LT AFP, largest tumor diameter and the number of nodules to predict the post-LT HCC recurrence, but the characteristics of their study population (western participants with predominantly HCV) was different. The gene discussed is AFP; the disease is hepatocellular carcinoma.